AKT1 and breast cancer: In breast cancer, KIF18A overexpression is correlated with tumor grade, metastasis and poor survival, while ablation of KIF18A dramatically restrains proliferation of breast cancer cells in vitro and in vivo via inhibiting PI3K/Akt pathway [23].